The reiteration of a Buy rating and maintenance of a $26 price target by a reputable analyst like Joseph Stringer from Needham is likely to instill confidence among investors and could lead to a positive short term impact on Phathom Pharmaceuticals' stock price. Analyst ratings, especially from well-regarded financial institutions, can significantly influence investor sentiment and stock prices.